OMOtto Muzik

Otto Muzik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Otto Muzik has a total of 442 co-authors. Here are the top co-authors by number of shared publications:

  • Vaibhav A. Diwadkar

    Department of Psychiatry and Behavioral Neurosciences Wayne State University School of Medicine Detroit Michigan USA

    9 shared publications
  • Csaba Juhász

    Department of Pediatrics and Translational Imaging Laboratory, Wayne State University School of Medicine, Detroit, USA

    6 shared publications
  • James Janisse

    Pathology and Family Medicine, Wayne State University, Detroit, Michigan; and

    5 shared publications
  • Thomas Beyer

    Quantitative Imaging and Medical Physics Team, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria

    5 shared publications
  • Geoffrey R. Barger

    Department of Neurology, Wayne State University School of Medicine, Detroit, USA

    4 shared publications
  • Harry T. Chugani

    Departments of Pediatrics, Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, USA

    4 shared publications

Latest Publications

  • Open Access

    Preliminary Results on the Added Value of Parametric Images Derived from 18F-fluoroethyl-L-tryptophan PET for Posttreatment Glioblastoma Assessment

    by Csaba Juhász, Geoffrey R. Barger, Michael Dominello, Natasha L. Robinette, Parthasarathi Chamiraju, Huailei Jiang, Otto Muzik

    Background: Increased amino acid transport in gliomas allows imaging of metabolically active tumor volume by PET. Tryptophan analog PET radiotracers can provide additional information by tracking tumoral metabolism via the upregulated immunosuppressive tryptophan-kynurenine pathway. We tested the recently developed tryptophan analog PET tracer [ 18 F]-fluoro-ethyl-L-tryptophan ([ 18 F]FETrp) for detecting post-treatment glioblastoma while using a non-invasive approach to generate parametric tryptophan metabolic maps and comparing them with static tracer uptake maps and contrast-enhanced MRI. Methods: Five patients (age: 22–67 years) with previously treated glioblastoma underwent [ 18 F]FETrp PET/CT imaging. A dynamic acquisition protocol sampled the brain and blood pool non-invasively using the FlowMotion Multiparametric PET software (Siemens Healthineers). Parametric brain images of the unidirectional uptake rate constant (K i ), characterizing irreversible tryptophan trapping and the volume of distribution (V D ) were fused with static uptake (SUV) maps and contrast-enhanced brain MRI. Voxels with elevated K i , V D , and SUV were defined, and their spatial associations with contrast-enhanced volumes were characterized by their % volume overlap and the distance between their centroids. Results: A substantial spatial volume overlap was observed between MRI contrast-enhancing regions and elevated static [ 18 F]FETrp uptake and V D . In contrast, the overlap between contrast-enhancing regions and elevated K i metabolic volumes was low (0–16%), with high K i areas extending deeper into non-enhancing brain (7–33 mm centroid distance). These non-enhancing high K i areas showed new contrast-enhancement on follow-up MRI, consistent with tumor progression. Conclusions: Areas of high tryptophan metabolism detected by [ 18 F]FETrp PET-derived parametric (K i ) maps extend outside the contrast-enhancing glioblastoma mass in adjacent non-enhancing brain regions that can be missed or underestimated by static uptake images. Consequently, [ 18 F]FETrp PET metabolic maps have the potential for enhanced detection of non-enhancing glioma infiltration for improved radiation or surgical treatment planning.


  • Human regulatory systems in the age of abundance: A predictive processing perspective

    by Otto Muzik, Vaibhav A. Diwadkar

    Human regulatory systems largely evolved under conditions of food and information scarcity but are now being forced to deal with abundance. The impact of abundance and the inability of human regulatory systems to adapt to it have fed a surge in dual health challenges: (1) a rise in obesity related to food abundance and (2) a rise in stress and anxiety related to information abundance. No single framework has been developed to describe why and how the transition from scarcity to abundance has been so challenging. Here, we provide a speculative model based on predictive processing. We suggest that whereas scarcity (above destructive lower bounds like famine or information voids) preserves the fidelity of the relationship between prediction errors and predictions, abundance distorts this relationship. Furthermore, prediction error minimization is enhanced under scarcity (as the number of competing states in the niche is restricted), whereas the opposite is true under abundance. We also discuss how abundance warps the fundamental drive for seeking novelty by fueling the brain's exploration (as opposed to exploitation) mode. Ameliorative strategies for regulating food and information abundance may largely depend on simulating scarcity, that environmental condition to which human regulatory systems have adapted over millennia.


  • Open Access

    The impact of a focused behavioral intervention on brain cannabinoid signaling and interoceptive function: Implications for mood and anxiety

    by Otto Muzik, Timothy Mann, John Kopchick, Asadur Chowdury, Mario Yacou, Jamie Vadgama, Daniel Bonello, Vaibhav A. Diwadkar


  • The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of Cancer

    by Otto Muzik, Anthony F. Shields, Geoffrey R. Barger, Huailei Jiang, Parthasarathi Chamiraju, Csaba Juhász

    Purpose Preclinical studies showed the tryptophan analog PET radiotracer 1-(2-18F-fluoroethyl)-L-tryptophan (18F-FETrp) to accumulate in various tumors, including gliomas, and being metabolized via the immunosuppressive kynurenine pathway. In this first-in-human study, we tested the use 18F-FETrp-PET in patients with neuroendocrine and brain tumors. Procedures We applied dynamic brain imaging in patients with gliomas (n = 2) and multi-pass 3D whole-body PET scans in patients with neuroendocrine tumors (n =4). Semiquantitative analysis of organ and tumor tracer uptake was performed using standardized uptake values (SUVs). In addition, organ dosimetry was performed based on extracted time–activity curves and the OLINDA software. Results Neuroendocrine tumors showed an early peak (10-min post-injection) followed by washout. Both gliomas showed prolonged 18F-FETrp accumulation plateauing around 40 min and showing heterogeneous uptake including non-enhancing tumor regions. Biodistribution showed moderate liver uptake and fast clearance of radioactivity into the urinary bladder; the estimated effective doses were similar to other 18F-labeled radioligands. Conclusions The study provides proof-of-principle data for the safety and potential clinical value of 18F-FETrp-PET for molecular imaging of human gliomas.


  • Open Access

    The First Human Application of an F-18-labeled Tryptophan Analog for PET Imaging of Cancer

    by Otto Muzik, Anthony F. Shields, Geoffrey R. Barger, Huailei Jiang, Parthasarathi Chamiraju, Csaba Juhász

    Purpose. Preclinical studies showed the tryptophan analog PET radiotracer 1-(2-18F-fluoroethyl)-L-tryptophan (18F-FETrp) to accumulate in various tumors, including gliomas, and being metabolized via the immunosuppressive kynurenine pathway. In this first-in-human study, we tested the use 18F-FETrp-PET in patients with neuroendocrine and brain tumors. Procedures. We applied dynamic brain imaging in patients with gliomas (n = 2) and multi-pass 3D whole-body PET scans in patients with neuroendocrine tumors (n =4). Semiquantitative analysis of organ and tumor tracer uptake was performed using standardized uptake values (SUVs). In addition, organ dosimetry was performed based on extracted time-activity curves and the OLINDA software. Results. Neuroendocrine tumors showed an early peak (10-min post-injection) followed by washout. Both gliomas showed prolonged 18F-FETrp accumulation plateauing around 40-min and showing heterogeneous uptake including non-enhancing tumor regions. Biodistribution showed moderate liver uptake and fast clearance of radioactivity into the urinary bladder; the estimated effective doses were similar to other 18F-labeled radioligands. Conclusions. The study provides proof-of-principle data for the safety and potential clinical value of 18F-FETrp-PET for molecular imaging of human gliomas.

  • Depth and hierarchies in the predictive brain: From reaction to action

    by Otto Muzik, Vaibhav A. Diwadkar

    The human brain is a prediction device, a view widely accepted in neuroscience. Prediction is a rational and efficient response that relies on the brain's ability to create and employ generative models to optimize actions over unpredictable time horizons. We argue that extant predictive frameworks while compelling, have not explicitly accounted for the following: (a) The brain's generative models must incorporate predictive depth (i.e., rely on degrees of abstraction to enable predictions over different time horizons); (b) The brain's implementation scheme to account for varying predictive depth relies on dynamic predictive hierarchies formed using the brain's functional networks. We show that these hierarchies incorporate the ascending processes (driven by reaction), and the descending processes (related to prediction), eventually driving action. Because they are dynamically formed, predictive hierarchies allow the brain to address predictive challenges in virtually any domain. By way of application, we explain how this framework can be applied to heretofore poorly understood processes of human behavioral thermoregulation. Although mammalian thermoregulation has been closely tied to deep brain structures engaged in autonomic control such as the hypothalamus, this narrow conception does not translate well to humans. In addition to profound differences in evolutionary history, the human brain is bestowed with substantially increased functional complexity (that itself emerged from evolutionary differences). We argue that behavioral thermoregulation in humans is possible because, (a) ascending signals shaped by homeostatic sub‐networks, interject with (b) descending signals related to prediction (implemented in interoceptive and executive sub‐networks) and action (implemented in executive sub‐networks). These sub‐networks cumulatively form a predictive hierarchy for human thermoregulation, potentiating a range of viable responses to known and unknown thermoregulatory challenges. We suggest that our proposed extensions to the predictive framework provide a set of generalizable principles that can further illuminate the many facets of the predictive brain.This article is categorized under: Neuroscience > Behavior Philosophy > Action Psychology > Prediction


  • Open Access

    Fully Automated, Fast Motion Correction of Dynamic Whole-Body and Total-Body PET/CT Imaging Studies

    by Lalith Kumar Shiyam Sundar, Martin Lyngby Lassen, Sebastian Gutschmayer, Daria Ferrara, Anna Calabrò, Josef Yu, Kilian Kluge, Yiran Wang, Lorenzo Nardo, Philip Hasbak, et al.

    We introduce the Fast Algorithm for Motion Correction (FALCON) software, which allows correction of both rigid and nonlinear motion artifacts in dynamic whole-body (WB) images, irrespective of the PET/CT system or the tracer. Methods: Motion was corrected using affine alignment followed by a diffeomorphic approach to account for nonrigid deformations. In both steps, images were registered using multiscale image alignment. Moreover, the frames suited to successful motion correction were automatically estimated by calculating the initial normalized cross-correlation metric between the reference frame and the other moving frames. To evaluate motion correction performance, WB dynamic image sequences from 3 different PET/CT systems (Biograph mCT, Biograph Vision 600, and uEXPLORER) using 6 different tracers (18F-FDG, 18F-fluciclovine, 68Ga-PSMA, 68Ga-DOTATATE, 11C-Pittsburgh compound B, and 82Rb) were considered. Motion correction accuracy was assessed using 4 different measures: change in volume mismatch between individual WB image volumes to assess gross body motion, change in displacement of a large organ (liver dome) within the torso due to respiration, change in intensity in small tumor nodules due to motion blur, and constancy of activity concentration levels. Results: Motion correction decreased gross body motion artifacts and reduced volume mismatch across dynamic frames by about 50%. Moreover, large-organ motion correction was assessed on the basis of correction of liver dome motion, which was removed entirely in about 70% of all cases. Motion correction also improved tumor intensity, resulting in an average increase in tumor SUVs by 15%. Large deformations seen in gated cardiac 82Rb images were managed without leading to anomalous distortions or substantial intensity changes in the resulting images. Finally, the constancy of activity concentration levels was reasonably preserved (<2% change) in large organs before and after motion correction. Conclusion: FALCON allows fast and accurate correction of rigid and nonrigid WB motion artifacts while being insensitive to scanner hardware or tracer distribution, making it applicable to a wide range of PET imaging scenarios. Visual Abstract


  • Top Cited Papers
    Open Access

    Fully-automated, semantic segmentation of whole-body 18 F-FDG PET/CT images based on data-centric artificial intelligence

    by Lalith Kumar Shiyam Sundar, Josef Yu, Otto Muzik, Oana Kulterer, Barbara J Fueger, Daria Kifjak, Thomas Nakuz, Hiyung Min Shin, Annika Katharina Sima, Daniela Kitzmantl, et al.

    We introduce Multi-Organ Objective Segmentation (MOOSE) software that generates subject-specific, multi-organ segmentations using data-centric AI principles to facilitate high-throughput systemic investigations of the human body via whole-body PET imaging. Methods: Image data from two PET/CT systems (uEXPLORER and Siemens TruePoint TrueView) was used in training MOOSE. For non-cerebral structures, a total 50 WB-CT images were used; 30 of which were acquired from healthy controls (HC, 14M/16F) and 20 datasets were acquired from oncology patients (14M/6F). Non-cerebral tissues consisted of 13 abdominal organs, 20 bone segments, subcutaneous fat, visceral fat, psoas, and skeletal muscle. An expert panel performed manual segmentation of all non-cerebral structures except for subcutaneous, visceral fat, and skeletal muscle, which was semi-automatically segmented using thresholding. A majority-voting algorithm was used to generate a 'reference standard' segmentation. From the 50 CT datasets, 40 were used for training and 10 for testing purposes. For cerebral structures, 34 18F-FDG PET/MRI brain image volumes were used from 10 HC (5M/5F imaged twice) and 14 non-lesional epilepsy patients (7M/7F). Only 18F-FDG PET images were considered for training: 24/34 and 10/34 volumes were used for training and testing, respectively. The dice score coefficient (DSC) was used as the primary and the average symmetric surface distance (ASSD) as a secondary metric to evaluate the automated segmentation performance. Results: An excellent overlap between the reference labels and MOOSE-derived organ segmentations was observed: 92% of non-cerebral tissues showed DSC values of >0.90, while a few organs exhibited lower DSC values (e.g., adrenal glands (0.72), pancreas (0.85), and bladder (0.86)). In comparison, the median DSC values of brain subregions derived from PET images were lower. Only 29% of the brain segments had a median DSC of >0.90, while segmentation of 60% of regions yielded a median DSC of 0.80-0.89. Results of the ASSD analysis demonstrated that the average distance between the reference standard and the automatically segmented tissue surfaces (organs, bones, brain regions) lies within the size of image voxels (2mm). Conclusion: The proposed segmentation pipeline MOOSE allows automatic segmentation of 120 unique tissues from whole-body 18F-FDG PET/CT images with high accuracy.


  • Effective connectivity of brain networks controlling human thermoregulation

    by Otto Muzik, Shahira Baajour, Asadur Chowdury, Vaibhav A. Diwadkar

    Homeostatic centers in the mammalian brainstem are critical in responding to thermal challenges. These centers play a prominent role in human thermoregulation, but humans also respond to thermal challenges through behavior modification. Behavioral modifications are presumably sub served by interactions between the brainstem and interoceptive, cognitive and affective elements in human brain networks. Prior evidence suggests that interoceptive regions such as the insula, and cognitive/affective regions such as the orbitofrontal cortex and anterior cingulate cortex are crucial. Here we used dynamic causal modeling (DCM) to discover likely generative network architectures and estimate changes in the effective connectivity between nodes in a hierarchically organized thermoregulatory network (homeostatic–interoceptive–cognitive/affective). fMRI data were acquired while participants (N = 20) were subjected to a controlled whole body thermal challenge that alternatingly evoked sympathetic and parasympathetic responses. Using a competitive modeling framework (ten competing modeling architectures), we demonstrated that sympathetic responses (evoked by whole-body cooling) resulted in more complex network interactions along two ascending pathways: (i) homeostatic interoceptive and (ii) homeostatic cognitive/affective. Analyses of estimated connectivity coefficients demonstrated that sympathetic responses evoked greater network connectivity in key pathways compared to parasympathetic responses. These results reveal putative mechanisms by which human thermoregulatory networks evince a high degree of contextual sensitivity to thermoregulatory challenges. The patterns of the discovered interactions also reveal how information propagation from homeostatic regions to both interoceptive and cognitive/affective regions sub serves the behavioral repertoire that is an important aspect of thermoregulatory defense in humans.


  • Open Access

    Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic 18F-FDG PET Brain Studies

    by Lalith Kumar Shiyam Sundar, David Iommi, Otto Muzik, Zacharias Chalampalakis, Eva-Maria Klebermass, Marius Hienert, Lucas Rischka, Rupert Lanzenberger, Andreas Hahn, Ekaterina Pataraia, et al.

    This work set out to develop a motion-correction approach aided by conditional generative adversarial network (cGAN) methodology that allows reliable, data-driven determination of involuntary subject motion during dynamic 18F-FDG brain studies. Methods: Ten healthy volunteers (5 men/5 women; mean age ± SD, 27 ± 7 y; weight, 70 ± 10 kg) underwent a test–retest 18F-FDG PET/MRI examination of the brain (n = 20). The imaging protocol consisted of a 60-min PET list-mode acquisition contemporaneously acquired with MRI, including MR navigators and a 3-dimensional time-of-flight MR angiography sequence. Arterial blood samples were collected as a reference standard representing the arterial input function (AIF). Training of the cGAN was performed using 70% of the total datasets (n = 16, randomly chosen), which was corrected for motion using MR navigators. The resulting cGAN mappings (between individual frames and the reference frame [55–60 min after injection]) were then applied to the test dataset (remaining 30%, n = 6), producing artificially generated low-noise images from early high-noise PET frames. These low-noise images were then coregistered to the reference frame, yielding 3-dimensional motion vectors. Performance of cGAN-aided motion correction was assessed by comparing the image-derived input function (IDIF) extracted from a cGAN-aided motion-corrected dynamic sequence with the AIF based on the areas under the curves (AUCs). Moreover, clinical relevance was assessed through direct comparison of the average cerebral metabolic rates of glucose (CMRGlc) values in gray matter calculated using the AIF and the IDIF. Results: The absolute percentage difference between AUCs derived using the motion-corrected IDIF and the AIF was (1.2% + 0.9%). The gray matter CMRGlc values determined using these 2 input functions differed by less than 5% (2.4% + 1.7%). Conclusion: A fully automated data-driven motion-compensation approach was established and tested for 18F-FDG PET brain imaging. cGAN-aided motion correction enables the translation of noninvasive clinical absolute quantification from PET/MR to PET/CT by allowing the accurate determination of motion vectors from the PET data itself. Visual Abstract